Ikarian Capital’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Ikarian Capital’s Portfolio AGTC Stock Details AGTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-412,293	Closed	-$440K	–	225
2022 Q1	$440K	Buy	412,293 +21,899	+6%	+$39.8K	0.06%	141
2021 Q4	$742K	Hold	390,394	–	–	0.11%	112
2021 Q3	$1.18M	Sell	390,394 -25,490	-6%	-$90.8K	0.08%	152
2021 Q2	$1.63M	Hold	415,884	–	–	0.13%	142
2021 Q1	$2.11M	Sell	415,884 -130,000	-24%	-$674K	0.07%	198
2020 Q4	$2.23M	Hold	545,884	–	–	0.1%	148
2020 Q3	$2.65M	Hold	545,884	–	–	0.19%	97
2020 Q2	$3.02M	Hold	545,884	–	–	0.24%	93
2020 Q1	$1.79M	Buy	545,884 +345,000	+172%	+$1.82M	0.13%	100
2019 Q4	$908K	Buy	+200,884	New	+$635K	0.15%	82

Other funds holding AGTC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCM

Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

IVM

InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Colony Group Boston, Massachusetts $6.66B AUM 18.65% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Ikarian Capital's AGTC Position: Q2 2022 in Review

Ikarian Capital sold out of Applied Genetic Technologies Corporation (AGTC) in Q2 2022, closing a stake of 412,293 shares — an estimated $440K sold.

Ikarian Capital first reported a position in AGTC in Q4 2019 and held it in 10 quarters. The position peaked at $3.02M in Q2 2020. 47 funds tracked by Wall St. Rank hold AGTC as of Q2 2022.

Ikarian Capital reported no remaining Applied Genetic Technologies Corporation position as of Q2 2022 after selling out during the quarter.
Ikarian Capital sold 412,293 Applied Genetic Technologies Corporation shares in Q2 2022, an estimated $440K.
Ikarian Capital first reported a position in Applied Genetic Technologies Corporation in Q4 2019 and held it in 10 quarters.
Ikarian Capital's Applied Genetic Technologies Corporation position peaked at $3.02M in Q2 2020.
47 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q2 2022.

Based on Ikarian Capital's 13F filing for Q2 2022, filed 12 Aug 2022.